Prelude Therapeutics Inc SEC filings PRLD
Prelude Therapeutics Inc has 389 filings in SEC EDGAR's recent list, going back to Jul 11, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 21, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 20, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Other events
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Nov 4, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 17, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Other events
|
Sep 19, 2025 | Sep 18, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Other events
|
Apr 25, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 28, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Other events
|
Dec 11, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Other events
|
Sep 13, 2024 | Sep 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 12, 2024 | Jun 12, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
May 16, 2024 | Apr 8, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2024 | Apr 8, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 1, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
May 19, 2023 | May 18, 2023 |
| 8-K |
Current report
Other events
|
May 17, 2023 | May 17, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 14, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 23, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2022 | Jun 17, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2022 | Apr 6, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2022 | Mar 16, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 9, 2022 | Mar 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 16, 2022 | Feb 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 3, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 12, 2021 | Nov 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2021 | Sep 16, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 19, 2021 | Jul 15, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2021 | May 12, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 17, 2021 | Mar 17, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2021 | Mar 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2021 | Jan 22, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 4, 2021 | Jan 4, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Material agreement
|
Nov 4, 2020 | Nov 1, 2020 |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRLD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmington, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1678660
- Former names
- Prelude Therapeutics Inc. (until Oct 20, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.